Fraunhofer USA Center for Molecular Biotechnology Awarded National Institutes of Health (NIH) Contract for "Vaccine Technologies to Advance Next Generation Anthrax Vaccines"
12/4/2012 10:59:23 AM
More...
|
Fraunhofer USA Center for Molecular Biotechnology Release: CMBVaccine Innovators Convene to Discuss New Technologies
3/26/2012 6:15:48 AM
More...
|
Fraunhofer USA Center for Molecular Biotechnology Confirms Interim Results for its Plant-Produced H1N1 Influenza Vaccine
3/21/2012 6:09:48 AM
More...
|
Fraunhofer USA Center for Molecular Biotechnology Release: Funding Awarded for Biological Countermeasure Reagent Development
9/7/2011 10:20:54 AM
More...
|
Fraunhofer USA Center for Molecular Biotechnology Announces Positive Phase 1 Interim Results for Its Plant-Produced H1N1 Influenza Vaccine
6/2/2011 11:04:26 AM
More...
|
Fraunhofer USA Center for Molecular Biotechnology Initiates Phase I Clinical Trial for Avian (H5N1) Influenza Vaccine
12/6/2010 10:31:50 AM
More...
|
Fraunhofer USA Center for Molecular Biotechnology Plant Produced H1N1 Vaccine Begins Phase 1 Clinical Trial
9/20/2010 6:28:58 AM
More...
|
iBio, Inc. (IBIO) and Fraunhofer USA Center for Molecular Biotechnology Execute Business Development and Marketing Agreement with GE Healthcare
9/1/2010 8:40:20 AM
More...
|
iBio, Inc. (IBPM) and Fraunhofer USA Center for Molecular Biotechnology Enter Agreement to Provide Global Access for Bill & Melinda Gates Foundation Vaccines
6/3/2010 9:52:18 AM
More...
|
iBio, Inc. (IBPM) Announces Rights Grant for Anthrax-Plague Combination Vaccine To Fraunhofer USA Center for Molecular Biotechnology
4/7/2010 8:50:41 AM
More...
|
|